16 cardiology practices to pay $17.7M+ for false claims allegations 

Sixteen separate cardiology practices across 12 states have agreed to pay a total of more than $17.7 million to resolve allegations they overbilled Medicare for diagnostic radiopharmaceuticals. 

Advertisement

Here are the settling medical practices and associated physicians have agreed to pay the following amounts, according to a Dec. 20 news release from the Justice Department. 

  • Western Kentucky Heart & Lung Associates and Mohammed Kazimuddin, MD: $6,750,000 (Bowling Green)
  • Heart Clinic of Paris (Texas) and Arjumand Hashmi, MD: $2.6 million 
  • Scranton (Pa.) Cardiovascular Physician Services and  Jasjit Walia, MD, and Preet Randhawa, MD: $2.4 million
  • Shannon Clinic: $996,856 (San Angelo, Texas)
  • Edward Leahey Professional Association and Edward Leahey,MD: $894,679 (Morristown, N.J.)
  • Metropolitan Cardiovascular Consultants and Ayim Djamson, MD: $846,888 (Lanham, Md.)
  • Cardiology Center of New Jersey, Mario Criscito, MD, Frank Iacovone, MD, and Sameer Kaul, MD: $740,000 (Clifton)
  • Clovis (N.M.) Cardiology Associates and Mahamadu Fuseini, MD: $600,000
  • Family Medical Specialty Clinic, Melecio Abordo, MD, and June Abadilla, MD: $409,594 (Paducah, Ky.)
  • James Higgins, MD: $395,537 (California, Md.)
  • TrustCare Health: $279,407 (Ridgeland, Miss.)
  • Taj Medical: $240,000 (Los Angeles)
  • White River Diagnostic Clinic, Margaret Kuykendall, MD, and Seth Barnes, MD: $234,490 (Batesville, Ariz.)
  • Boulder (Colo.) Medical Center: $160,000 
  • Wellspring Cardiac Care P.A.: $50,000 (Towson, Md.)
  • VeinGuard Heart and Vascular Center and Fareeha Khan, MD: $195,000 (Tysons, Va.)

These cardiology practices allegedly regularly reported inflated acquisition costs to Medicare for diagnostic radiopharmaceuticals and radioisotopes bound to biological molecules used to diagnose and treat certain cancers and diseases. 

 

The settling practices engaged in this conduct allegedly for at least a year, and in some instances for more than a decade. 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Cardiology

  • Cardiology is expanding increasingly into ASCs as CMS policy updates, advancements in cardiovascular innovation and population health concerns necessitate more…

  • As more cardiac procedures move into the ambulatory setting, developers are taking different approaches to what that shift should look…

Advertisement

Comments are closed.